Drug approval process in US, Europe and India and its regulatory requirements: A Review

Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 3

Abstract

Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for marketing authorization Application (MAA) approval of new drugs. In this present exertion, study expresses the drug approval process and regulatory requirements according to US Food and Drug Administration (UDFDA), European Medical Agency (EMA) and Central Drug Standard Control Organization (CDSCO) (1).

Authors and Affiliations

Krishnasis Chakraborty, Kavita Yadav

Keywords

Related Articles

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING TABLETS OF LAFUTIDINE BY EMPLOYING EFFERVESCENT TECHNOLOGY

In the present research work gastro retentive floating matrix formulation of Lafutidine by using various polymers were developed. Initially analytical method development was done for the drug molecule. Absorption maxima...

SELF-MEDICATION IN RELATION TO HEALTH LOCUS OF CONTROL

Present study was conducted to examine the association of self- medication and health locus of control. It was also intended to know the health problems for which people do self – medication and the medicines which are m...

LIPOSOME AS A DRUG DELIVERY CARRIER-A REVIEW

The evolution of the science and technology of liposomes as a drug carrier has passed through a number of distinct phases. Because they exhibit peculiar properties due to their structure, chemical composition amphiphilic...

A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA

The present study reviews the regulations of herbal drugs in the EU, US and India and throws light upon issues related to their clinical trials. Herbal drugs have been used for a long time in different systems of health...

Comparative study of the harmonization of pharmaceutical regulations in the western and central sub-regions of Africa

The harmonization of pharmaceutical regulations in Africa aims to offer States a coherent body of texts and practices by combining limited resources. The objective of this study was to describe policies to harmonize phar...

Download PDF file
  • EP ID EP426930
  • DOI 10.22270/ijdra.v6i3.266
  • Views 122
  • Downloads 0

How To Cite

Krishnasis Chakraborty, Kavita Yadav (2018). Drug approval process in US, Europe and India and its regulatory requirements: A Review. International Journal of Drug Regulatory Affairs, 6(3), 31-39. https://europub.co.uk/articles/-A-426930